Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 409.74 billion. The enterprise value is 453.66 billion.

Market Cap	409.74B
Enterprise Value	453.66B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Bio Plus has 58.87 million shares outstanding. The number of shares has increased by 3.11% in one year.

Current Share Class	58.87M
Shares Outstanding	58.87M
Shares Change (YoY)	+3.11%
Shares Change (QoQ)	+11.00%
Owned by Insiders (%)	32.71%
Owned by Institutions (%)	6.35%
Float	39.45M

Valuation Ratios

The trailing PE ratio is 21.07.

PE Ratio	21.07
Forward PE	n/a
PS Ratio	5.14
PB Ratio	2.45
P/TBV Ratio	2.88
P/FCF Ratio	n/a
P/OCF Ratio	20.63
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.33, with an EV/FCF ratio of -6.15.

EV / Earnings	23.15
EV / Sales	5.69
EV / EBITDA	14.33
EV / EBIT	16.03
EV / FCF	-6.15

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.34.

Current Ratio	0.80
Quick Ratio	0.49
Debt / Equity	0.34
Debt / EBITDA	1.78
Debt / FCF	-0.76
Interest Coverage	99.53

Financial Efficiency

Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 9.51%.

Return on Equity (ROE)	15.40%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	9.51%
Return on Capital Employed (ROCE)	16.53%
Revenue Per Employee	659.33M
Profits Per Employee	161.99M
Employee Count	n/a
Asset Turnover	0.35
Inventory Turnover	2.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.63% in the last 52 weeks. The beta is 0.60, so Bio Plus's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+51.63%
50-Day Moving Average	7,486.20
200-Day Moving Average	6,496.53
Relative Strength Index (RSI)	38.94
Average Volume (20 Days)	641,898

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 79.78 billion and earned 19.60 billion in profits. Earnings per share was 330.29.

Revenue	79.78B
Gross Profit	51.95B
Operating Income	28.30B
Pretax Income	21.72B
Net Income	19.60B
EBITDA	31.65B
EBIT	28.30B
Earnings Per Share (EPS)	330.29

Full Income Statement

Balance Sheet

The company has 29.01 billion in cash and 56.23 billion in debt, giving a net cash position of -27.22 billion or -462.42 per share.

Cash & Cash Equivalents	29.01B
Total Debt	56.23B
Net Cash	-27.22B
Net Cash Per Share	-462.42
Equity (Book Value)	166.90B
Book Value Per Share	2,567.57
Working Capital	-21.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.86 billion and capital expenditures -93.62 billion, giving a free cash flow of -73.76 billion.

Operating Cash Flow	19.86B
Capital Expenditures	-93.62B
Free Cash Flow	-73.76B
FCF Per Share	-1,252.93

Full Cash Flow Statement

Margins

Gross margin is 65.12%, with operating and profit margins of 35.48% and 24.57%.

Gross Margin	65.12%
Operating Margin	35.48%
Pretax Margin	27.23%
Profit Margin	24.57%
EBITDA Margin	39.67%
EBIT Margin	35.48%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.72%.

Dividend Per Share	50.00
Dividend Yield	0.72%
Dividend Growth (YoY)	-28.57%
Years of Dividend Growth	n/a
Payout Ratio	21.41%
Buyback Yield	-3.11%
Shareholder Yield	-2.39%
Earnings Yield	4.78%
FCF Yield	-18.00%

Dividend Details

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 23, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio Plus has an Altman Z-Score of 2.82. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.82
Piotroski F-Score	n/a